Results 91 to 100 of about 43,470 (269)
Challenges, Difficulties, and Delayed Diagnosis of Multiple Myeloma
Background: Multiple myeloma (MM) is a heterogeneous plasma cell malignancy with non-specific symptoms and disease heterogeneity at clinical and biological levels.
Tugba Zorlu +5 more
doaj +1 more source
COMPARATIVE EFFECT OF APHERESIS vs ATORVASTATIN/APHERESIS ON MARKERS OF INFLAMMATION IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA [PDF]
Objective: Patients with Familial Hypercholesterolemia (FH) have increased cardiovascular events. Clinical trials have demonstrated that lowering circulating lipid levels by LDL-apheresis has beneficial effects on prognosis.
Bigazzi, Federico +4 more
core
Biosimilar G-CSF versus filgrastim and lenograstim in healthy unrelated volunteer hematopoietic stem cell donors [PDF]
The World Marrow Donor Organization recommends original granulocyte-colony stimulating factor (G-CSF) for the mobilization of stem cells in healthy unrelated hematopoietic stem cell donors. We report the comparison of a biosimilar G-CSF (Zarzio) with two
Bogusz, K +10 more
core +1 more source
Behrouz Mansouri Taleghani +1 more
openaire +2 more sources
Automated cell count for blood component quality control
Abstract Background Accurate quantification of residual leukocytes (rWBC) and red blood cells (rRBC) in leukoreduced blood components is essential to ensure product quality and transfusion safety. Conventional manual flow cytometry techniques are time‐consuming and analyst‐dependent.
Gemma Aran +13 more
wiley +1 more source
PCSK9 monoclonal antibodies and lipoprotein apheresis for lowering lipoprotein(a): making choices in an era of RNA-based therapies [PDF]
Massimiliano Ruscica +2 more
openalex +1 more source
Narrative review of strategies for blood product shelf‐life extension
Transfusion, EarlyView.
Mike Akaraphanth +7 more
wiley +1 more source
Abstract Background Heparin combined with sodium citrate has been used in leukocytapheresis for pediatric patients. Since 2022, we have performed leukocytapheresis using a highly concentrated sodium citrate solution (HSC, 5.32%) instead of acid citrate dextrose solution A (ACD‐A).
Keiko Fujii +8 more
wiley +1 more source
Lipoprotein glomerulopathy treated with LDL-apheresis (Heparin-induced Extracorporeal Lipoprotein Precipitation system): a case report. [PDF]
INTRODUCTION: Lipoprotein glomerulopathy is a glomerulonephritis which was described for the first time by Saito in 1989 and is currently acknowledged as a separate nosological entity.
ALBERTAZZI, Alberto +6 more
core +2 more sources

